Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FELRB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,589
Award facts
- Contract value 100% obligated
- $10,588.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,588.89 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on December 23, 2025, with an ultimate completion date of December 24, 2025, represents one of numerous purchase orders placed under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The delivery order carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, distributing a comprehensive range of products including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support Department of Defense healthcare operations.
This delivery order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion DLA acquisition strategy established to supply recurring medical needs of military healthcare facilities worldwide. DMS Pharmaceutical Group's underlying single-award Indefinite Delivery Contract (SPE2DR) was awarded on November 13, 2025, with a $499,999,999 ceiling value and completion date of December 31, 2036. The contract structure includes a 30-month base period with three 30-month option periods, positioning DMS Pharmaceutical Group as one of multiple regional prime vendor contractors authorized to fulfill the diverse and specialized pharmaceutical requirements of the Department of Defense military medical system. No subcontractors are identified in the award documentation.
Quick answers
Who was awarded contract SPE2DU26FELRB?
SPE2DU26FELRB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DU26FELRB worth?
The government has obligated $10,589 on SPE2DU26FELRB.
Is contract SPE2DU26FELRB an order under another contract?
Yes. SPE2DU26FELRB is a delivery order under SPE2DU25D9421, an indefinite delivery contract.
Was contract SPE2DU26FELRB competed?
The extent of competition for SPE2DU26FELRB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award